Azelastine Hydrochloride
Product Images NDC 53002-1803

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 53002-1803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of Azelastine Hydrochloride showing the molecular framework including phenyl rings, a piperidine ring, and chlorine substitution, alongside the hydrochloride (HCl) moiety.*

FDA Label Image

Label Image (Lbl530021803)

The image shows a label for Azelastine Hydrochloride Ophthalmic Solution 0.05% by RPK Pharmaceuticals, Inc. It is intended for ophthalmic use with instructions to instill 1 drop into the affected eye(s) twice a day or as directed. The label includes dosage information, storage instructions, and barcode, along with fields for patient name, prescriber name, and other clinical details. The container size is 6 mL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.